C. Crandall

发表

Predictors of breast discomfort among women initiating menopausal hormone therapy

G. Greendale, C. Crandall, D. Markovic, 2009, Menopause.

Mammographic density in a multiethnic cohort

J. Cauley, B. Sternfeld, L. Habel, 2007, Menopause.

Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole genome sequencing studies at scale

Ivana V. Yang, Andrew D. Johnson, Ryan D. Hernandez, 2020, Nature Genetics.

Title Quality indicators for multiple sclerosis Permalink

P. Shekelle, R. Hays, J. Haselkorn, 2010 .

Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study

J. Manson, R. Prentice, R. Chlebowski, 2018, Menopause.

Association of breast cancer and its therapy with menopause-related symptoms

P. Ganz, G. Greendale, C. Crandall, 2004, Menopause.

Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women’s Health Initiative Study

J. Manson, A. LaCroix, J. Cauley, 2018, Journal of General Internal Medicine.

Optimism, Cynical Hostility, Falls, and Fractures: The Women's Health Initiative Observational Study (WHI‐OS)

Stephen F. Smagula, J. Cauley, J. Wactawski‐Wende, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy

J. Manson, R. Prentice, B. Howard, 2019, Annals of Internal Medicine.

Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials

J. Manson, J. Cauley, G. Anderson, 2012, Breast Cancer Research and Treatment.

Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis

R. Chlebowski, P. Newcomb, C. Crandall, 2018, JNCI cancer spectrum.

Health information on the Internet: how will it affect patient care?

C. Crandall, C Crandall, 2000, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

Physical Functioning Among Women Aged 80 Years and Older With Previous Fracture.

C. Lewis, J. Cauley, J. Robbins, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Women's Health: A New JAMA Clinical Insights Series.

E. Livingston, C. Crandall, 2019, JAMA.

Obesity and associated lifestyles modify the effect of glucose metabolism‐related genetic variants on impaired glucose homeostasis among postmenopausal women

J. Papp, E. Sobel, Zuo-Feng Zhang, 2016, Genetic epidemiology.

Laboratory workup for osteoporosis

C. Crandall, C. Crandall, 2003, Postgraduate medicine.

Combination treatment of osteoporosis: a clinical review.

C. Crandall, 2002, Journal of women's health & gender-based medicine.

The role of serial bone mineral density testing for osteoporosis.

C. Crandall, 2001, Journal of women's health & gender-based medicine.

Impact of Body Weight Dynamics Following Intentional Weight Loss on Fracture Risk: Results from The Action for Health in Diabetes Study

C. Lewis, S. Kritchevsky, R. Casanova, 2018, JBMR plus.

Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor symptoms but not negative mood in the early perimenopausal transition: Study of Women's Health Across the Nation.

S. Crawford, C. Derby, E. Gold, 2021, Maturitas.

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan

C. Crandall, D. Ganz, Takahiro Mori, 2021, Archives of Osteoporosis.

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan

C. Crandall, D. Ganz, Takahiro Mori, 2021, Archives of Osteoporosis.

Development of a comprehensive health-risk prediction tool for postmenopausal women

Jennifer G. Robinson, J. Cauley, H. Hedlin, 2019, Menopause.

Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries

Ivana V. Yang, Zhaohui S. Qin, Andrew D. Johnson, 2018, Nature Communications.

Oestrogen plus progestogen did not reduce the risk of coronary heart disease in postmenopausal women

C. Crandall, 2004 .

Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study.

J. Cauley, G. Greendale, C. Crandall, 2012, The Journal of clinical endocrinology and metabolism.

Estrogen replacement therapy and colon cancer: a clinical review.

C. Crandall, C. Crandall, 1999, Journal of women's health & gender-based medicine.

Bone mineral density and adjuvant therapy in breast cancer survivors

P. Ganz, G. Greendale, C. Crandall, 2004, Breast Cancer Research and Treatment.

Vitamin A intake and osteoporosis: a clinical review.

C. Crandall, 2004, Journal of women's health.

Women’s Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy

J. Manson, C. Lewis, Karen C Johnson, 2014, Menopause.

Population-Based Osteoporosis Primary Prevention and Screening for Quality of Care in Osteoporosis, Current Osteoporosis Reports

W. Leslie, C. Crandall, C. Crandall, 2019, Current Osteoporosis Reports.

Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians

Jennifer S. Lin, T. Wilt, D. Owens, 2022, Annals of Internal Medicine.

Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians

Jennifer S. Lin, T. Wilt, D. Owens, 2022, Annals of Internal Medicine.

The Women's Health Initiative: A Landmark Resource for Skeletal Research Since 1992

J. Cauley, C. Crandall, C. Crandall, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

No Increase in Fractures After Stopping Hormone Therapy: Results From the Women’s Health Initiative

J. Manson, A. LaCroix, C. Lewis, 2016, The Journal of clinical endocrinology and metabolism.

Relationship of Social Connectedness With Decreasing Physical Activity During the COVID-19 Pandemic Among Older Women Participating in the Women’s Health Initiative Study

M. Stefanick, C. Crandall, J. Larson, 2022, The journals of gerontology. Series A, Biological sciences and medical sciences.

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

T. Wilt, A. Qaseem, R. Mustafa, 2020, Annals of Internal Medicine.

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan

D. Kiel, S. Cummings, O. Bruyère, 2022, Osteoporosis International.

Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.

J. Manson, J. Cauley, P. Newcomb, 2017, Obstetrics and gynecology.

Socioeconomic status in relation to incident fracture risk in the Study of Women’s Health Across the Nation

T. Seeman, G. Greendale, C. Crandall, 2014, Osteoporosis International.

Trajectories of femoral neck strength in relation to the final menstrual period in a multi-ethnic cohort

J. Cauley, G. Greendale, C. Crandall, 2013, Osteoporosis International.

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative

L. Carbone, J. Wactawski‐Wende, K. Johnson, 2020, JBMR plus.

Association between soft drink consumption and osteoporotic fractures among postmenopausal women: the Women's Health Initiative.

A. LaCroix, C. Crandall, K. Masaki, 2019, Menopause.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

J. Manson, Karen C Johnson, R. Chlebowski, 2018, Menopause.

Sodium Intake and Osteoporosis. Findings From the Women's Health Initiative.

R. Prentice, L. Carbone, J. Wactawski‐Wende, 2016, The Journal of clinical endocrinology and metabolism.

Associations of menopausal vasomotor symptoms with fracture incidence.

J. Manson, A. LaCroix, J. Cauley, 2015, The Journal of clinical endocrinology and metabolism.

Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative

Mathew D. Sorensen, L. Carbone, N. Watts, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS)

J. Manson, C. Crandall, J. Larson, 2021, Menopause.

Who should be screened for osteoporosis?

K. Ensrud, C. Crandall, C. Crandall, 2021, Marcus and Feldman's Osteoporosis.

Performance of FRAX and FRAX‐Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry

L. Lix, W. Leslie, J. Schousboe, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians

T. Wilt, A. Qaseem, R. Mustafa, 2019, Annals of Internal Medicine.

K. Matthews, S. Crawford, E. Gold, 2013, American journal of epidemiology.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

J. Manson, Karen C Johnson, R. Chlebowski, 2018, Menopause.

Knowledge and Needs of Resident Physicians Regarding Osteoporosis: A Nationwide Survey of Residents

D. Bauer, D. Elashoff, C. Crandall, 2021, JBMR plus.

When to measure BMD in patients being treated for osteoporosis

C. Crandall, 2001, Postgraduate medicine.

A Clinical Review

C. Crandall, 2017 .

RisedronateA Clinical Review

C. Crandall, 2001 .

Risedronate: a clinical review.

C. Crandall, 2001, Archives of internal medicine.

Lasofoxifene reduced vertebral fractures in postmenopausal women with osteoporosis

C. Crandall, 2010, Annals of Internal Medicine.

Raloxifene reduced vertebral fractures and breast cancer regardless of prior hormone therapy use in women

O. Johnell, C. Crandall, Wickerham Dl, 2005 .

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide

C. Crandall, D. Ganz, Takahiro Mori, 2019, JBMR plus.

Estradiol and Follicle‐Stimulating Hormone as Predictors of Onset of Menopause Transition‐Related Bone Loss in Pre‐ and Perimenopausal Women

J. Cauley, G. Greendale, C. Crandall, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis

S. Crawford, E. Gold, G. Greendale, 2009, Menopause.

C‐Reactive Protein, Bone Strength, and Nine‐Year Fracture Risk: Data From the Study of Women's Health Across the Nation (SWAN)

J. Cauley, Y. Ouchi, G. Greendale, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bisphosphonates for Osteopenia in Postmenopausal Women-Reply.

K. Ensrud, C. Crandall, 2020, JAMA.

In older postmenopausal women with osteopenia, zoledronate reduced fragility fractures at 6 years

K. Ensrud, C. Crandall, 2019, Annals of Internal Medicine.

Genomic insights into the mechanism of NK3R antagonists for treatment of menopausal vasomotor symptoms

K. Ruth, C. Crandall, A. Murray, 2022, medRxiv.

Calcium plus vitamin D was associated with increased cardiovascular risk in women not taking personal calcium supplements

J. Cauley, C. Crandall, 2011, Annals of Internal Medicine.

Cumulative Endogenous Estrogen Exposure Is Associated With Postmenopausal Fracture Risk: The Women's Health Initiative Study

J. Cauley, E. Leblanc, C. Crandall, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials

J. Kanis, J. Cauley, E. McCloskey, 2022, Osteoporosis International.

Menopausal Hormone Therapy.

J. Manson, C. Crandall, J. Shifren, 2019, JAMA.

Parity, lactation, bone strength, and 16-year fracture risk in adult women: findings from the Study of Women's Health Across the Nation (SWAN).

J. Cauley, G. Greendale, C. Crandall, 2015, Bone.

Bone Health During the Menopause Transition and Beyond.

C. Crandall, A. Karlamangla, S. M. Burnett-Bowie, 2018, Obstetrics and gynecology clinics of North America.

Gene testing to predict tamoxifen-induced hot flashes: new biological insights.

C. Crandall, C. Crandall, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in serum endogenous estrogen concentrations are mediators of the effect of low-dose oral estradiol on vasomotor symptoms

K. Ensrud, S. Reed, C. Crandall, 2022, Menopause.

Review: vasomotor symptoms peak at 1 year after final menstrual period and may persist for many years

C. Crandall, 2008, Evidence-based medicine.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults

T. Wilt, A. Qaseem, R. Mustafa, 2020, Annals of Internal Medicine.

Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN)

K. Matthews, S. Crawford, E. Gold, 2017, Menopause.

Adult bone strength of children from single-parent families: the Midlife in the United States Study

T. Seeman, G. Greendale, C. Crandall, 2015, Osteoporosis International.

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan

D. Kiel, S. Cummings, O. Bruyère, 2022, Osteoporosis International.

Bisphosphonates for Postmenopausal Osteoporosis.

K. Ensrud, C. Crandall, 2019, Journal of the American Medical Association (JAMA).

Association of Menopausal Vasomotor Symptoms With Increased Bone Turnover During the Menopausal Transition

S. Crawford, C. Tseng, E. Gold, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period.

C. Tseng, G. Greendale, C. Crandall, 2013, The Journal of clinical endocrinology and metabolism.

Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women’s Health Initiative, USA

J. Cauley, L. Carbone, Simin Liu, 2019, BMJ Open.

Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.

C. Crandall, C. Crandall, 2003, Journal of women's health.

Marital histories, marital support, and bone density: findings from the Midlife in the United States Study

T. Seeman, G. Greendale, C. Crandall, 2014, Osteoporosis International.

Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries

Ryan D. Hernandez, May E. Montasser, Min A. Jhun, 2018, Nature Communications.

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials

J. Kanis, J. Cauley, E. McCloskey, 2022, Osteoporosis International.

Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.

L. Carbone, N. Watts, K. Ensrud, 2020, JAMA internal medicine.

Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan

C. Crandall, D. Ganz, T. Mori, 2017, Osteoporosis International.

Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review

C. Crandall, C. Crandall, 2015, Current Osteoporosis Reports.

Can We Pave the Pathway to Fracture Prevention?

C. Crandall, 2019, Annals of Internal Medicine.

Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.

Huiyong Zheng, John F Randolph, S. Crawford, 2011, The Journal of clinical endocrinology and metabolism.

Pre- and Early Peri-menopausal Physical Function and Risk of Cardiovascular Events: The Study of Women’s Health Across the Nation

I. Janssen, B. Appelhans, E. Strotmeyer, 2022, Journal of aging and health.

Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal

K. Ensrud, S. Reed, C. Crandall, 2022, JAMA network open.

Quality Indicators for the Screening and Care of Urinary Incontinence in Vulnerable Elders

C. Crandall, C. Fung, B. Spencer, 2007, Journal of the American Geriatrics Society.

Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.

A. LaCroix, K. Ensrud, J. Fine, 2017, The American journal of medicine.

Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Orthopedic nursing.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Journal of orthopaedic trauma.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition

D. Kiel, C. Cooper, M. Hochberg, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.

G. Ursin, G. Greendale, C. Crandall, 2006, Archives of internal medicine.

Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA

C. Crandall, D. Ganz, T. Mori, 2017, Osteoporosis International.

Update in Women's Health

C. Crandall, J. Pregler, C. Crandall, 2005, Annals of Internal Medicine.

Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.

S. Crawford, C. Derby, C. Crandall, 2019, Menopause.

Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation.

K. Matthews, B. Sternfeld, E. Gold, 2009, American journal of epidemiology.

The Study of Women's Health Across the Nation

K. Matthews, B. Sternfeld, E. Gold, 2009 .

Tolterodine: a clinical review.

C. Crandall, 2001, Journal of women's health & gender-based medicine.

Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.

C. Crandall, 2002, Journal of women's health.

Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma.

Ivana V. Yang, Andrew D. Johnson, Ryan D. Hernandez, 2019, Chest.

Safety of vaginal estrogens: a systematic review.

C. Crandall, N. Santoro, A. Diamant, 2020, Menopause.

Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.

S. Crawford, E. Gold, C. Crandall, 2006, The American journal of medicine.

Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

J. Sinsheimer, S. Crawford, L. Habel, 2009, Breast Cancer Research.

Genetic variation and hot flashes: A systematic review.

J. Sinsheimer, M. Maglione, C. Crandall, 2020, The Journal of clinical endocrinology and metabolism.

Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study

S. Horvath, J. Manson, J. Sinsheimer, 2017, Menopause.

Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study

S. Ingles, D. J. Van Den Berg, G. Ursin, 2012, Menopause.

Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN)

G. Greendale, C. Crandall, Mei-hua Huang, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Active, but not passive cigarette smoking was inversely associated with mammographic density

L. Habel, N. Oestreicher, E. Gold, 2009, Cancer Causes & Control.

Narrative Review: Hyperkyphosis in Older Persons

C. Crandall, D. Kado, K. Prenovost, 2007, Annals of Internal Medicine.

Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing

J. Cauley, K. Ensrud, B. Taylor, 2017, Journal of General Internal Medicine.

Dietary intake related to prevalent functional limitations in midlife women.

M. Yosef, C. Crandall, M. Jannausch, 2008, American journal of epidemiology.

Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, J. Wactawski‐Wende, 2017, The Journal of clinical endocrinology and metabolism.

Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures

Paul G Shekelle, Yee-Wei Lim, Aneesa Motala, 2014, Annals of Internal Medicine.

Serum prolactin levels are positively associated with mammographic density in postmenopausal women

S. Ingles, E. Barrett-Connor, G. Ursin, 2007, Breast Cancer Research and Treatment.

Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis : Update of a 2007 Report Executive Summary

P. Shekelle, Y. Lim, C. Crandall, 2012 .

Parathyroid hormone for treatment of osteoporosis.

C. Crandall, 2002, Archives of internal medicine.

Socioeconomic status over the life-course and adult bone mineral density: the Midlife in the U.S. Study.

T. Seeman, G. Greendale, C. Crandall, 2012, Bone.

Association of sleep disturbance and sexual function in postmenopausal women

Emily W. Gower, J. Manson, C. Crandall, 2017, Menopause.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

J. Manson, J. Cauley, R. Chlebowski, 2017, Menopause.

Estrogen plus progestin did not reduce the risk for coronary heart disease in postmenopausal women.

C. Crandall, 2004, ACP Journal Club.

Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort

S. Kardia, P. Peyser, Jennifer A. Smith, 2021, Menopause.

Genetic evidence for causal relationships between age at natural menopause and the risk of aging-associated adverse health outcomes

T. Assimes, M. Stefanick, C. Crandall, 2022, medRxiv.

History of socioeconomic disadvantage and allostatic load in later life.

T. Seeman, C. Crandall, T. Gruenewald, 2012, Social science & medicine.

Childhood socioeconomic status and adult femoral neck bone strength: findings from the Midlife in the United States Study.

T. Seeman, G. Greendale, C. Crandall, 2013, Bone.

Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

T. Seeman, G. Greendale, C. Crandall, 2014, The Journal of clinical endocrinology and metabolism.

Multi-System Dysregulation and Bone Strength : Findings from the Study of Midlife in the Unites States

T. Seeman, G. Greendale, C. Crandall, 2014 .

Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review.

E. Barrett-Connor, C. Crandall, C. Crandall, 2013, Endocrinology and metabolism clinics of North America.

The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

M. Pike, B. Reboussin, G. Ursin, 2005, American journal of epidemiology.

Physical activity and mammographic density in a cohort of midlife women.

B. Sternfeld, L. Habel, N. Oestreicher, 2008, Medicine and science in sports and exercise.

Menopausal bone changes and incident fractures in diabetic women: a cohort study

J. Cauley, K. Sutton-Tyrrell, E. Strotmeyer, 2011, Osteoporosis International.

Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

J. Manson, W. Willett, F. Grodstein, 2019, Menopause.

Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI)

C. Cooper, J. Kanis, L. Carbone, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Risk of Fracture in Women with Sarcopenia, Low Bone Mass, or Both

R. Wallace, K. Johnson, C. Crandall, 2017, Journal of the American Geriatrics Society.

Insulin Resistance and Bone Strength: Findings From the Study of Midlife in the United States

T. Seeman, G. Greendale, C. Crandall, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial

J. Manson, J. Cauley, J. Wactawski‐Wende, 2016, Menopause.

Fracture risk assessment without race/ethnicity information.

J. Cauley, G. Greendale, C. Crandall, 2012, The Journal of clinical endocrinology and metabolism.

Socioeconomic status, race, and bone turnover in the Midlife in the US Study

T. Seeman, G. Greendale, C. Crandall, 2012, Osteoporosis International.

Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures.

A. LaCroix, J. Cauley, J. Robbins, 2021, JAMA internal medicine.

After the initial fracture in postmenopausal women, where do subsequent fractures occur?

A. LaCroix, J. Cauley, J. Robbins, 2021, EClinicalMedicine.

Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative

Jennifer G. Robinson, J. Manson, C. Crandall, 2021, Menopause.

Osteoporosis Screening in Younger Postmenopausal Women.

K. Ensrud, C. Crandall, C. Crandall, 2020, JAMA.

Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

J. Cauley, J. Wactawski‐Wende, C. Crandall, 2023, Osteoporosis International.

Strong Bones, Strong Body.

C. Crandall, 2019, Obstetrics and gynecology clinics of North America.

Management of Menopausal Symptoms: A Review.

J. Manson, C. Crandall, Jaya M Mehta, 2023, JAMA.

Genetic polymorphisms and obesity influence estradiol decline during the menopause

B. Nan, S. Kardia, D. McConnell, 2011, Clinical endocrinology.

Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross‐Sectional Survey

C. Crandall, K. Mara, P. Schnatz, 2019, Mayo Clinic proceedings.

Predictors of vasomotor symptoms among breast cancer survivors

M. Pennell, E. Paskett, C. Crandall, 2018, Journal of Cancer Survivorship.

Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation

C. Derby, C. Crandall, R. Thurston, 2010, Climacteric : the journal of the International Menopause Society.

Beyond frequency: who is most bothered by vasomotor symptoms?

K. Matthews, R. Hess, J. Bromberger, 2008, Menopause.

Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2011, Menopause.

Phase 2 data on a new treatment for hot flushes in women with breast cancer

P. Ganz, C. Crandall, 2022, The Lancet.

Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study

J. Manson, R. Prentice, J. Cauley, 2017, Menopause.

Vasomotor symptoms and insulin resistance in the study of women's health across the nation.

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2012, The Journal of clinical endocrinology and metabolism.

Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition

S. Crawford, G. Greendale, D. McConnell, 2011, Menopause.

Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials

A. LaCroix, J. Cauley, J. Robbins, 2019, JBMR plus.

Vasomotor Symptoms and Lipid Profiles in Women Transitioning Through Menopause

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2012, Obstetrics and gynecology.

Evidence map of ductal carcinoma in situ management options.

Kathryn E. Bouskill, P. Ganz, J. Miles, 2019, Menopause.

Baseline age and time to major fracture in younger postmenopausal women

A. LaCroix, K. Ensrud, J. Fine, 2015, Menopause.

Osteoporosis Screening in Postmenopausal Women 50 to 64 Years Old: Comparison of US Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative

A. LaCroix, J. Cauley, J. Robbins, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians

Jennifer S. Lin, T. Wilt, D. Owens, 2023, Annals of Internal Medicine.

Breast tenderness after initiation of conjugated equine estrogens and mammographic density change

J. Manson, J. Cauley, G. Anderson, 2012, Breast Cancer Research and Treatment.

Increases in Serum Estrone Sulfate Level Are Associated with Increased Mammographic Density during Menopausal Hormone Therapy

S. Ingles, E. Barrett-Connor, G. Ursin, 2008, Cancer Epidemiology Biomarkers & Prevention.

Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)

L. Habel, N. Oestreicher, F. Modugno, 2008, Breast Cancer Research and Treatment.

Dietary Patterns and Fractures in Postmenopausal Women: Results From the Women's Health Initiative.

J. Cauley, L. Carbone, J. Shikany, 2016, JAMA internal medicine.

Psychosocial stress and bone loss among postmenopausal women: results from the Women’s Health Initiative

Chengcheng Hu, C. Crandall, Y. Klimentidis, 2019, Journal of Epidemiology & Community Health.

Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.

A. LaCroix, J. Cauley, J. Robbins, 2014, The Journal of clinical endocrinology and metabolism.

Serial Bone Density Measurement for Osteoporosis Screening.

W. Leslie, C. Crandall, 2021, JAMA.

Impact of Competing Risk of Mortality on Association of Weight Loss With Risk of Central Body Fractures in Older Men: A Prospective Cohort Study

C. Lewis, L. Fredman, J. Cauley, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Update in Women's Health: Evidence Published in 2013

C. Crandall, J. Pregler, C. Crandall, 2014, Annals of Internal Medicine.

Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study

J. Cauley, J. Wactawski‐Wende, C. Crandall, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.

J. Manson, J. Cauley, J. Wactawski‐Wende, 2015, The Journal of clinical endocrinology and metabolism.

Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk

Zuo-Feng Zhang, T. Rohan, C. Crandall, 2017, PloS one.

Bone resorption and fracture across the menopausal transition: the Study of Women’s Health Across the Nation

J. Cauley, L. Meyn, G. Greendale, 2012, Menopause.

Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study

J. Cauley, B. Sternfeld, G. Greendale, 2013, Osteoporosis International.

Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

G. Greendale, C. Crandall, A. Karlamangla, 2016, The Journal of clinical endocrinology and metabolism.

Characteristics of Self‐Reported Sleep and the Risk of Falls and Fractures: The Women's Health Initiative (WHI)

J. Cauley, K. Stone, K. Barbour, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Postmenopausal weight change and incidence of fracture: post hoc findings from Women’s Health Initiative Observational Study and Clinical Trials

J. Cauley, S. Going, J. Wactawski‐Wende, 2015, BMJ : British Medical Journal.

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study

B. Reboussin, G. Ursin, G. Greendale, 2005, Breast Cancer Research.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians

T. Wilt, A. Qaseem, R. Mustafa, 2019, Annals of Internal Medicine.

Air pollution and decreased bone mineral density among Women's Health Initiative participants

A. Baccarelli, I. Ionita-Laza, D. Liao, 2023, EClinicalMedicine.

The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, J. Wactawski‐Wende, 2017, The American journal of clinical nutrition.

Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk

J. Papp, E. Sobel, Zuo-Feng Zhang, 2017, Breast Cancer Research and Treatment.

Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.

J. Cauley, P. Cawthon, K. Ensrud, 2022, The Journal of clinical endocrinology and metabolism.

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

L. Kuller, J. Cauley, G. Anderson, 2009, Archives of internal medicine.

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

A. LaCroix, C. Kooperberg, R. Chlebowski, 2016, Menopause.

Vasomotor symptoms and accelerated epigenetic aging in the Women's Health Initiative (WHI).

M. Levine, S. Horvath, L. Hou, 2020, The Journal of clinical endocrinology and metabolism.

Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials.

K. Ensrud, S. Reed, C. Crandall, 2022, Maturitas.

Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.

E. Barrett-Connor, B. Reboussin, G. Greendale, 2006, Journal of women's health.

An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels

Ivana V. Yang, Andrew D. Johnson, Ryan D. Hernandez, 2018, Circulation.

Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women

L. Hou, Zuo-Feng Zhang, R. Chlebowski, 2017, Menopause.

Relation of level of exercise, age, and weight-cycling history to weight and eating concerns in male and female runners.

K. Brownell, J. Wilmore, J. Rodin, 1992, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

The association between mammographic breast density and bone mineral density in the study of women's health across the nation.

Barbara Sternfeld, J. Cauley, B. Sternfeld, 2007, Annals of epidemiology.